androstane-3,17-diol has been researched along with Blood Pressure, High in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schooling, CM | 1 |
| Estafanous, FG; Koehler, LS; Kraenzler, EJ; Starr, NJ; Wong, D | 1 |
1 trial(s) available for androstane-3,17-diol and Blood Pressure, High
| Article | Year |
|---|---|
Comparison of cardiovascular effects of pipecuronium versus vecuronium in patients receiving sufentanil anesthesia for myocardial revascularization.
Topics: Androstane-3,17-diol; Anesthesia, Intravenous; Anesthetics; Blood Pressure; Cardiac Output; Central Venous Pressure; Coronary Artery Bypass; Female; Fentanyl; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Muscle Relaxants, Central; Neuromuscular Nondepolarizing Agents; Pipecuronium; Piperazines; Pulmonary Wedge Pressure; Sufentanil; Vascular Resistance; Vecuronium Bromide | 1991 |
1 other study(ies) available for androstane-3,17-diol and Blood Pressure, High
| Article | Year |
|---|---|
Androgen activity, ischaemic heart disease and risk factors among men in NHANES III.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Androstane-3,17-diol; Biomarkers; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetic Angiopathies; Glycated Hemoglobin; Hemoglobins; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Risk Factors; Stroke; Testosterone; United States; Waist Circumference; Young Adult | 2013 |